Skip to main content
. 2020 Jul 16;12(7):667. doi: 10.3390/pharmaceutics12070667

Figure 7.

Figure 7

Percentage of positive (a) dividing ARPE-19 cells, and (b) differentiated RPE cells measured by flow cytometry upon 5 h of treatment with fluorescent siRNA/dsDNA incorporated into different carriers. Dividing ARPE-19 cells were transfected with 50 nM of FAM-IL-6 siRNA, the differentiated ARPE-19 with 100 nM of FAM-IL-6 siRNA, and the 4-week matured hESC-RPE with 50 nM of Alexa Fluor 488 dsDNA (21-mer). L2000: Lipofectamine 2000; DF4: DharmaFect 4. Data are presented as mean + SD, n = 3.